Your session is about to expire
← Back to Search
SIRI Checklist + Peer Coaching for HIV Prevention in Opioid Users (SHAPE Trial)
N/A
Recruiting
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from enrollment to 3 month post-enrollment
Awards & highlights
No Placebo-Only Group
Summary
This trial will develop and test a checklist to increase evidence-based treatment for rural people who use drugs, including long-acting injectable agents. The hypothesis is that hospital-based care models can successfully engage rural people in effective addiction treatment and infection prevention, which is foundational to Ending the HIV epidemic in rural states.
Who is the study for?
This trial is for individuals over 18 with opioid use disorder who are HIV negative and have serious injection-related infections. They must be receiving care at UAB Hospital and able to give informed consent, not excluded due to acute illness or intoxication.
What is being tested?
The study is testing a SIRI Checklist alone, an Enhanced Peer Recovery Coach alone, and the combination of both interventions. The goal is to improve addiction treatment and prevent infections in rural drug users by using hospital-based care models.
What are the potential side effects?
Since this trial focuses on behavioral interventions rather than medications, traditional side effects are not applicable. However, participants may experience emotional discomfort or stress during recovery coaching sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ enrollment until 3 months post-enrollment.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~enrollment until 3 months post-enrollment.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability Assessment
Feasibility Assessment
Secondary study objectives
Number of outpatient visit(s)attended related to HIV and/or addiction services following hospitalization.
Number of prescription for medications for opioid use disorder (MOUD)
Number of prescriptions for PrEP (pre-exposure prophylaxis)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: SIRI Checklist + Enhanced Peer Recovery CoachExperimental Treatment1 Intervention
A standardized checklist of clinical items to review by the attending hospitalist with participants.
Participants will receive the addiction medicine protocol plus peer recovery coaching beginning while hospitalized and continuing for up to 1 month after randomization. As part of this study, Peer recovery coaches will initiate contact with patients weekly in person during the hospitalization and at the time of hospital discharge. The enhanced part of the peer coach is the post-hospital follow-up. Following discharge, contact will continue weekly in person, by phone, and/or via text messaging based on the participant's preferences for 1 month.
Group II: SIRI ChecklistExperimental Treatment1 Intervention
A standardized checklist of clinical items to review by the attending hospitalist with participants.
Group III: Enhanced Peer Recovery CoachExperimental Treatment1 Intervention
Participants will receive the addiction medicine protocol plus peer recovery coaching beginning while hospitalized and continuing for up to 1 month after randomization. As part of this study, Peer recovery coaches will initiate contact with patients weekly in person during the hospitalization and at the time of hospital discharge. The enhanced part of the peer coach is the post-hospital follow-up. Following discharge, contact will continue weekly in person, by phone, and/or via text messaging based on the participant's preferences for 1 month.
Group IV: Standard of CareActive Control1 Intervention
Participants will receive the stand hospital care while in-patient.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,656 Previous Clinical Trials
2,444,315 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am HIV negative and have a serious infection from injecting drugs.
Research Study Groups:
This trial has the following groups:- Group 1: SIRI Checklist + Enhanced Peer Recovery Coach
- Group 2: Standard of Care
- Group 3: SIRI Checklist
- Group 4: Enhanced Peer Recovery Coach
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Human Immunodeficiency Virus Infection Patient Testimony for trial: Trial Name: NCT05480956 — N/A